Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Inventory Average (2021 - 2025)

Historic Inventory Average for RxSight (RXST) over the last 5 years, with Q3 2025 value amounting to $28.6 million.

  • RxSight's Inventory Average rose 3503.14% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 3503.14%. This contributed to the annual value of $20.3 million for FY2024, which is 2142.51% up from last year.
  • Per RxSight's latest filing, its Inventory Average stood at $28.6 million for Q3 2025, which was up 3503.14% from $25.4 million recorded in Q2 2025.
  • RxSight's 5-year Inventory Average high stood at $28.6 million for Q3 2025, and its period low was $8.4 million during Q1 2022.
  • In the last 5 years, RxSight's Inventory Average had a median value of $18.6 million in 2024 and averaged $17.7 million.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 10193.39% in 2023, then soared by 675.36% in 2024.
  • Quarter analysis of 5 years shows RxSight's Inventory Average stood at $10.0 million in 2021, then surged by 56.37% to $15.6 million in 2022, then grew by 19.19% to $18.6 million in 2023, then rose by 20.7% to $22.5 million in 2024, then grew by 27.18% to $28.6 million in 2025.
  • Its Inventory Average stands at $28.6 million for Q3 2025, versus $25.4 million for Q2 2025 and $23.4 million for Q1 2025.